NeuroSense Therapeutics L...

NASDAQ: NRSN · Real-Time Price · USD
1.20
0.03 (2.56%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.42%
After-hours: Aug 15, 2025, 06:33 PM EDT

NeuroSense Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.19 -1.06 -1.34 -10.7
PEG Ratio
0.06 0.07 -0.00 0.13
PS Ratio
n/a n/a n/a n/a
PB Ratio
8.64 -5.71 2.50 2.97
P/FCF Ratio
-2.2 -1.28 -1.83 -17.16
P/OCF Ratio
-2.2 -1.28 -1.85 -17.35
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.03 -0.08 0.04 0.20
Quick Ratio
2.21 0.84 6.41 19.41
Current Ratio
2.21 0.84 4.28 19.12
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-31.84 -21.91 -903.47 -4.84
Return on Equity
-3.95 5.39 -1.87 -0.28
Return on Assets
-2.23 -3.18 -1.36 -0.22
Return on Invested Capital
-3.73 58.78 -2.03 -0.32
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a